Switch to:
Onyx Pharmaceuticals, Inc. (NAS:ONXX)
Change In Receivables
$12.1 Mil (As of Jun. 2013)

Onyx Pharmaceuticals, Inc.'s change in receivables for the quarter that ended in Jun. 2013 was $12.1 Mil. It means Onyx Pharmaceuticals, Inc.'s accounts receivables increased by $12.1 Mil from Mar. 2013 to Jun. 2013 .

Onyx Pharmaceuticals, Inc.'s change in receivables for the fiscal year that ended in Dec. 2012 was $-89.4 Mil. It means Onyx Pharmaceuticals, Inc.'s accounts receivables declined by $89.4 Mil from Dec. 2011 to Dec. 2012 .

Onyx Pharmaceuticals, Inc.'s accounts receivables for the quarter that ended in Jun. 2013 was $211.5 Mil.

Days sales outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed. Onyx Pharmaceuticals, Inc.'s days sales outstanding for the three months ended in Jun. 2013 was 125.77.

In Ben Graham’s calculation of liquidation value, Apple Inc's accounts receivables are only considered to be worth 75% of book value. Onyx Pharmaceuticals, Inc.'s liquidation value for the three months ended in Jun. 2013 was $387.8 Mil.


Definition

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.


Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days sales outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Onyx Pharmaceuticals, Inc.'s Days Sales Outstanding for the quarter that ended in Jun. 2013 is calculated as:

Days Sales Outstanding
=Account Receivable/Revenue*Days in Period
=211.501/153.026*91
=125.77

2. In Ben Graham’s calculation of liquidation value, Onyx Pharmaceuticals, Inc.'s accounts receivable are only considered to be worth 75% of book value:

Onyx Pharmaceuticals, Inc.'s liquidation value for the quarter that ended in Jun. 2013 is calculated as:

Liquidation Value
=Cash and Cash Equivalents-Total Liabilities+(0.75 * Account Receivable)+(0.5 * Inventory)
=750.456-535.643+0.75 * 211.501+0.5 * 28.768
=387.8

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

Days Sales Outstanding, Account Receivable, Revenue, NCAV, Cash and Cash Equivalents, Total Liabilities, Inventory


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Onyx Pharmaceuticals, Inc. Annual Data

Dec03Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12
ChangeInReceivables -0.6-0.4-3.3-4.94.6-31.1-15.60.0-6.5-89.4

Onyx Pharmaceuticals, Inc. Quarterly Data

Mar11Jun11Sep11Dec11Mar12Jun12Sep12Dec12Mar13Jun13
ChangeInReceivables 0.6-0.0-6.8-0.33.4-7.2-17.8-67.8-76.312.1
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK